These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30279351)

  • 1. Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers.
    Bartus É; Olajos G; Schuster I; Bozsó Z; Deli MA; Veszelka S; Walter FR; Datki Z; Szakonyi Z; Martinek TA; Fülöp L
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30279351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers.
    Fülöp L; Mándity IM; Juhász G; Szegedi V; Hetényi A; Wéber E; Bozsó Z; Simon D; Benkő M; Király Z; Martinek TA
    PLoS One; 2012; 7(7):e39485. PubMed ID: 22859942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Terminal Hypothesis for Alzheimer's Disease.
    Murray B; Sharma B; Belfort G
    ACS Chem Neurosci; 2017 Mar; 8(3):432-434. PubMed ID: 28186729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalent foldamer-based affinity assay for selective recognition of Aβ oligomers.
    Olajos G; Bartus É; Schuster I; Lautner G; Gyurcsányi RE; Szögi T; Fülöp L; Martinek TA
    Anal Chim Acta; 2017 Apr; 960():131-137. PubMed ID: 28193356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antigen-binding fragment of human gamma immunoglobulin prevents amyloid β-peptide folding into β-sheet to form oligomers.
    Valls-Comamala V; Guivernau B; Bonet J; Puig M; Perálvarez-Marín A; Palomer E; Fernàndez-Busquets X; Altafaj X; Tajes M; Puig-Pijoan A; Vicente R; Oliva B; Muñoz FJ
    Oncotarget; 2017 Jun; 8(25):41154-41165. PubMed ID: 28467807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
    Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
    ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates.
    Sörgjerd KM; Zako T; Sakono M; Stirling PC; Leroux MR; Saito T; Nilsson P; Sekimoto M; Saido TC; Maeda M
    Biochemistry; 2013 May; 52(20):3532-42. PubMed ID: 23614719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
    Klementieva O; Benseny-Cases N; Gella A; Appelhans D; Voit B; Cladera J
    Biomacromolecules; 2011 Nov; 12(11):3903-9. PubMed ID: 21936579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody against Small Aggregated Peptide Specifically Recognizes Toxic Aβ-42 Oligomers in Alzheimer's Disease.
    Bodani RU; Sengupta U; Castillo-Carranza DL; Guerrero-Muñoz MJ; Gerson JE; Rudra J; Kayed R
    ACS Chem Neurosci; 2015 Dec; 6(12):1981-9. PubMed ID: 26448453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
    Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
    J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure.
    Kokkoni N; Stott K; Amijee H; Mason JM; Doig AJ
    Biochemistry; 2006 Aug; 45(32):9906-18. PubMed ID: 16893191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ42 and Aβ40: similarities and differences.
    Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
    J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foldamer-Mediated Structural Rearrangement Attenuates Aβ Oligomerization and Cytotoxicity.
    Kumar S; Henning-Knechtel A; Chehade I; Magzoub M; Hamilton AD
    J Am Chem Soc; 2017 Nov; 139(47):17098-17108. PubMed ID: 29058422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic toxic Aβ
    Bobo C; Chaignepain S; Henry S; Vignaud H; Améadan A; Marchal C; Prado E; Doutch J; Schmitter JM; Nardin C; Lecomte S; Cullin C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1168-1176. PubMed ID: 28267577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.